• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS, INC VENACURE NEVERTOUCH FIBER; VENACURE ENDOVENOUS LASER TREATMENT FIBER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS, INC VENACURE NEVERTOUCH FIBER; VENACURE ENDOVENOUS LASER TREATMENT FIBER Back to Search Results
Model Number 11403001
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombus (2101)
Date of Event 12/18/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The reported defective device has yet to be returned to the manufacturer for a device evaluation.The firm is attempting to obtain the device.An investigation into the root cause for product problem is currently in progress.The results of the device evaluation will be sent via a follow up medwatch.Reference complaint (b)(4).
 
Event or Problem Description
As reported : a small clot advanced outside of the sheath when advancing fiber.They flushed the sheath and dilator and guidewire.Clot migrated into deep system.There was clot on the fiber once they pulled fiber out of body.Physician prescribed xalreto and will continue to follow up with patient.They saved the fiber.(patient 1).A similar incidence happened to another patient the following morning with dr.(b)(6) (patient 2, reference 1319211-2020-00002).Patient was reported as being stable post procedure.It was reported the disposable device is available for return to the manufacturer for a device evaluation.
 
Additional Manufacturer Narrative
As the reported device was not returned, angiodynamics was unable to perform a device evaluation.A photo was provided by the user.Based on the complaint description, the reported incident of a patient experienced a clot.The customer provided a photo which noted a clot that was removed from the fiber.A possible root cause of the clot per angiodynamics' engineer for this product states: "blood clots as shown in the attached photo do occasionally occur, but do not present a concern during a laser endovenous procedure", is most likely due to their blood chemistry and the presence of a foreign object in the body".A review of the device history records via ship history report was performed for the packaging and component lots for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly, and performance specifications.The instructions for use, which is supplied to the end user with this catalog number, states, "the potential complications include but are not limited to the following: vessel perforation, thrombosis, pulmonary embolism, phlebitis, hematoma, infection, skin pigmentation alteration, neovascularization, paresthesia due to thermal damage of adjacent sensory nerves, anesthetic tumescence, non-target irradiation, hemorrhage, necrosis, dehp exposure, skin burns and pain".Xarelto (blood thinner) was given to the patient by the physician to try and resolve the event.A review of the angiodynamics complaint system noted no trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Reference complaint (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENACURE NEVERTOUCH FIBER
Common Device Name
VENACURE ENDOVENOUS LASER TREATMENT FIBER
Manufacturer (Section D)
ANGIODYNAMICS, INC
603 queensbury avenue
queensbury NY 12804
MDR Report Key9582007
Report Number1319211-2020-00004
Device Sequence Number10896474
Product Code GEX
UDI-Device IdentifierH787114030010
UDI-PublicH787114030010
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K171921
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional,user faci
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 01/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/31/2022
Device Model Number11403001
Device Catalogue NumberH787114030010
Device Lot Number5497234
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/15/2020
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/19/2019
Supplement Date Received by Manufacturer12/19/2019
Initial Report FDA Received Date01/13/2020
Supplement Report FDA Received Date01/31/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-